MARANDA PAGE: Open Payments
NPI 1982105938 · COPPELL, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$302 in 16 payments from 9 companies in 2025. Trend: 2023 $684 · 2024 $324 · 2025 $302
Food & beverage: $302
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 3 | $54 |
| Novo Nordisk Inc | 3 | $47 |
| Indivior Inc. | 2 | $45 |
| ABBVIE INC. | 2 | $34 |
| Edwards Lifesciences Corporation | 1 | $34 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $33 |
| Astellas Pharma US Inc | 1 | $21 |
| Braeburn Inc. | 1 | $18 |
| Lilly USA, LLC | 1 | $15 |
Products named: PREVNAR 20, SUBLOCADE, SAPIEN 3 Ultra RESILIA, CAPLYTA, Veozah, QULIPTA, BRIXADI, Ozempic.
Industry payments across TX — which companies pay providers there.
